The Discounted Cash Flow (DCF) valuation of C4 Therapeutics Inc (CCCC) is (86.82) USD. With the latest stock price at 1.52 USD, the upside of C4 Therapeutics Inc based on DCF is -5812.1%.
Based on the latest price of 1.52 USD and our DCF valuation, C4 Therapeutics Inc (CCCC) is a sell. selling CCCC stocks now will result in a potential gain of 5812.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.0% - 9.3% | 7.6% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (300.75) - (51.73) | (86.82) |
| Upside | -19885.9% - -3503.0% | -5812.1% |